These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 26958063
21. Clinical spectrum of Kawasaki disease in infants. Tseng CF, Fu YC, Fu LS, Betau H, Chi CS. Zhonghua Yi Xue Za Zhi (Taipei); 2001 Mar; 64(3):168-73. PubMed ID: 11458622 [Abstract] [Full Text] [Related]
22. Kawasaki disease following SARS-CoV-2 infection: Stronger inflammation with no increase in cardiac complications. Roh DE, Lim YT, Kwon JE, Kim YH. Front Pediatr; 2022 Mar; 10():1036306. PubMed ID: 36467487 [Abstract] [Full Text] [Related]
23. Kawasaki disease: an evolving paradigm. Greco A, De Virgilio A, Rizzo MI, Tombolini M, Gallo A, Fusconi M, Ruoppolo G, Pagliuca G, Martellucci S, de Vincentiis M. Autoimmun Rev; 2015 Aug; 14(8):703-9. PubMed ID: 25882057 [Abstract] [Full Text] [Related]
24. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease. Han CL, Zhao SL. Med Sci Monit; 2018 Oct 11; 24():7264-7270. PubMed ID: 30307902 [Abstract] [Full Text] [Related]
27. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease. Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH. PLoS One; 2015 Oct 11; 10(12):e0144603. PubMed ID: 26658843 [Abstract] [Full Text] [Related]
28. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease. Amano Y, Akazawa Y, Yasuda J, Yoshino K, Kojima K, Kobayashi N, Matsuzaki S, Nagasaki M, Kawai Y, Minegishi N, Ishida N, Motoki N, Hachiya A, Nakazawa Y, Yamamoto M, Koike K, Takeshita T. Pediatr Rheumatol Online J; 2019 Jul 03; 17(1):34. PubMed ID: 31269967 [Abstract] [Full Text] [Related]
29. Profile of Kawasaki Disease in Adolescents: Is It Different? Advani N, Santoso LA, Sastroasmoro S. Acta Med Indones; 2019 Jan 03; 51(1):42-46. PubMed ID: 31073105 [Abstract] [Full Text] [Related]
32. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin. Platt B, Belarski E, Manaloor J, Ofner S, Carroll AE, John CC, Wood JB. JAMA Netw Open; 2020 Jan 03; 3(1):e1918565. PubMed ID: 31899532 [Abstract] [Full Text] [Related]
33. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM. Pediatrics; 2004 Dec 03; 114(6):e689-93. PubMed ID: 15545617 [Abstract] [Full Text] [Related]
36. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC. Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997 [Abstract] [Full Text] [Related]
37. Atypical desquamation in a 2.5-year-old boy with Kawasaki disease: A case report. Adib A, Fazel A, Nabavizadeh SH, Alyasin S, Kashef S. Electron Physician; 2017 Feb 17; 9(2):3764-3767. PubMed ID: 28465804 [Abstract] [Full Text] [Related]
38. Ulinastatin therapy in kawasaki disease. Iwashima S, Seguchi M, Matubayashi T, Ohzeki T. Clin Drug Investig; 2007 Feb 17; 27(10):691-6. PubMed ID: 17803344 [Abstract] [Full Text] [Related]
39. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease. Manlhiot C, Yeung RS, Chahal N, McCrindle BW. Pediatr Allergy Immunol; 2010 May 17; 21(3):515-21. PubMed ID: 20546528 [Abstract] [Full Text] [Related]